Flynn James E 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:09 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Flynn James E | 1,175,131 4.800% |
-630,906 (-34.93%) |
Filing |
| 2021-05-07 4:56 pm Purchase |
2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Flynn James E | 1,806,037 7.430% |
1,806,037 (New Position) |
Filing |